Global Personalized Medicines Market Overview

Market Scenario
The global personalized medicines market is expected to grow at a healthy CAGR of 10.3% during 2019-2026.
Personalized medicine are the medication that are based or prepared on individual patient or intended patient groups carrying certain biomarkers and are generated to satisfy the requirement of an individual patient based on the response produced by the patient suffering from a particular disease. During last decade there is a significant increase in the healthcare expenditure and number of patient suffering from chronic diseases.
The global personalized medicine market is majorly driven by increasing prevalence of chronic diseases such as diabetes and cancer, rising attention toward the genetics and developing technology. Favorable policies of the governments in relation to the personalized medicine and recent developments in the pharmacogenomics will fuel the growth of the market. 
However, high development costs, complexity of the drugs, and long approval time may slow the growth of the personalized medicines market during the forecast period.

The global personalized medicines market is segmented on the basis of products, applications and end users.
On the basis of products, the personalized medicines market is segmented into personalized nutrition & wellness, personalized medical care, personalized diagnostic, personalized therapeutic. Personalized nutrition & wellness are further segmented into nutrition care, alternative medicines care, medical retail, and others. Personalized medical care is sub-segmented into telemedicine & remote patient monitoring, EMR, and other.
On the basis of application, the personalized medicines market is segmented into disease treatment, biomarker identification, clinical research, and others. Disease treatment segment is further segmented into oncology, psychiatry, infectious diseases, cardiology, endocrinology, neurology, gastroenterology, rheumatology, and others. 
On the basis of end users, the personalized medicines market is segmented into hospitals & clinics, diagnostic laboratories and testing facilities, research laboratories & academic institutes, and others.
Figure: Global personalized medicines market, by products, 2018, (%)

Regional Analysis
America continues to dominate the global personalized medicines market owing to the presence of huge diabetic population, well developed technology, and high healthcare spending. According to the WHO, in 2015, 9.2% of the total Americas patients were suffering from diabetes. Moreover, strong government support and presence of leading players in this region have supported the growth of the Americas personalized medicine market. 
Europe accounts for the second leading market which is followed by Asia Pacific. Asia Pacific is the fastest growing market owing rapidly growing economies and huge patient population. Continuously increasing healthcare spending and increasing government support have supported the growth of the market in Asia Pacific region.
On the other hand, the Middle East & Africa holds the least share in the market but is expecting a healthy growth in coming future.

Key Players
Innovation is the organic strategy for the development of the market and major players in the market are investing a huge amount of the capital for the developing new and advanced products.
The key players in the market are: Siemens Healthcare GmbH (Germany), Quest Diagnostics (U.S.), Sanofi (France),Pfizer Inc. (U.S.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN (Germany), CELERA (U.S.), Amgen (U.S.), and 23andme (U.S.)
Global Personalized Medicines Market By Products
Personalized Nutrition & Wellness
Nutrition Care
Alternative medicines care
Medical Retail
Personalized Medical Care
Telemedicine & Remote Patient Monitoring
Personalized Diagnostic
Personalized Therapeutic
Global Personalized Medicines Market By Applications
Disease Treatment
Lung Cancer
Breast Cancer
Prostate Cancer
Infectious Diseases
Hepatitis B
Biomarker Identification
Clinical Research
Global Personalized Medicines Market By End Users
Hospitals & clinics
Diagnostic laboratories and testing facilities
Research Laboratories & Academic institutes

1.    Introduction
1.1.    Market Definition
1.2.    Market Scope
2.    Research Methodology
2.1.    Primary Research
2.2.    Secondary Sources
2.3.    Assumptions & Exclusions
3.    Market Overview
3.1.    Market Overview – Personalized Medicines, Type Landscape
3.2.    Research Report Segmentation & Scope
3.3.    Value Chain Analysis 
3.4.    Key Market Trend Analysis
3.4.1.    Market Drivers
3.4.2.    Market Restraint/Challenges
3.4.3.    Market Opportunities
3.5.    Porter’s Five Forces Analysis
3.6.    Potential Venture Avenues
3.7.    Market Share Analysis, 2016 
3.8.    Regulatory Framework
3.9.    Marketing Strategy
3.10.    Key wining Strategy
3.11.    Consumer Behavior Analysis
4.    Product Overview
4.1.    Introduction
4.2.    Market Size & Forecast, 2016 to 2026
4.2.1.    Personalized Nutrition & Wellness    Nutrition Care    Alternative Medicines Care    Medical Retail    Others
4.2.2.    Personalized Medical Care    Telemedicine & Remote Patient Monitoring    EMR    Other
4.2.3.    Personalized Diagnostic
4.2.4.    Personalized Therapeutic
5.    Application Overview
5.1.    Introduction 
5.2.    Market Size & Forecast, 2016 to 2026
5.2.1.    Disease Treatment    Oncology    Lung Cancer    Breast Cancer    Prostate Cancer    Others    Psychiatry    Infectious Diseases    HIV    Hepatitis B    Others    Cardiology    Endocrinology    Neurology    Gastroentrology    Rheumatology    Others
5.2.2.    Biomarker Identification
5.2.3.    Clinical Research
5.2.4.    Others
6.    End Users Overview
6.1.    Introduction
6.2.    Market Size & Forecast, 2016 to 2026
6.2.1.    Hospitals & clinics
6.2.2.    Diagnostic laboratories and testing facilities
6.2.3.    Research Laboratories & Academic institutes
6.2.4.    Others
7.    Regional Overview
7.1.    Introduction
7.2.    Market Size & Forecast, 2016 to 2026
7.2.1.    Americas    North America    U.S.    Canada    South America
7.2.2.    Europe    Western Europe    Germany    France    U.K.    Italy    Spain    Rest Of Western Europe    Eastern Europe
7.2.3.    Asia Pacific    China    Australia    Japan    India    Republic of Korea    Rest of Asia Pacific
7.2.4.    The Middle East & Africa    The Middle East    UAE    Saudi Arabia    Kuwait    Qatar    Rest of the Middle East    Africa
8.    Manufacturer/ Vendor Profile
8.1.    The following attributes will be considered while profiling key manufacturers in this industry: 
8.1.1.    Company Overview
8.1.2.    Financial Synopsis
8.1.3.    Recent Developments
8.1.4.    R&D Investments (if any)
8.1.5.    Strategy Overview (Analyst Perspective)
8.1.6.    Product Portfolio
8.2.    Companies Profiled
8.2.1.    Siemens Healthcare GmbH
8.2.2.    Quest Diagnostics 
8.2.3.    Sanofi
8.2.4.    Pfizer Inc. 
8.2.5.    Abbott
8.2.6.    F. Hoffmann-La Roche Ltd
8.2.7.    QIAGEN
8.2.8.    CELERA
8.2.9.    Amgen

Let us know more about your research need and we will customize an offer exclusively for you!
Let us know more about your research need and we will customize an offer exclusively for you!
Please Select Format
Enquiry About Report

More Information

Contact us
+1 321-441-4414
--- or ---


  • Linda Jacobson
    Director of Product Development

    Medical Devices manufacturing company at Canada

    I was looking for some elaborated details on blood bag got a reference from my colleague about them, and I was very much satisfied with the data on market segmentation and insights about global market, asked them if I can get it more customised hence they did elaborated it to huge 400 pages deep report in one week.Thanks guys will be back in future.

  • Mike Simmons
    Purchase Head

    Heavy machinery manufacturing company

    Did purchased a report from one of the vendor on Artificial Lift Market and I was depressed to see the very standard type of data included in the report, then again went back to hunt for something valuable and data driven report they asked me each and every details I want to see over the report and after a week of time got what I was looking for so not hesitant to refer back to them. Thanks victor for being prompt and professional.

  • Anna Stevenson
    Business Owner

    freelance software developer

    It’s been 8 years now I am developing and designing software as a freelance for various small and large scale organisations around globe and wanted to start my own software development consultancy firm, and I got hooked to their Mobile application market report and after a very thorough understanding of the report I have stepped my start-up into the customised mobile software market at Middle East, Africa and Asia Pacific.Thanks to Lee the Boss analyst  and victor for small discount.

  • Josh Bernard
    Owner, Designer, Artist

    Deals on customised automobile at USA

    I am one of the biggest enthusiast for custom jobs on cars, trucks and ships since childhood, so I own a custom automobile designing company and I was blown off to see beautiful custom paint work done on a Ford at one of the event and since that day I wanted to offer the same to my clients as well but I was not having too much of information on Electric paints, and fortunately I received message on LinkedIn from Data N Analysis team about their service, and now I am stuck  with three research report and contract signed for digital marketing as well. (Best of luck guys).

  • Neo Yang
    Chief Technical Officer

    Electronics Manufacturing company at Malaysia.

    Great team to have as a consultant, very sensible and professional service provided as per the scheduled timeline, what I like most about them is that they are straight forward with quality of service so if you are in hurry they will just say sorry we can’t compromise with our work. Look forward for more inputs guy’s thanks.